Turin Hospital Myeloma Unit
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Palumbo, Antonio
NCT01091831 / 2008-008599-15: Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects

Checkmark ASH 2014
Nov 2014 - Nov 2014: ASH 2014
Checkmark P3 data: ASH (MM)
Nov 2013 - Nov 2013: P3 data: ASH (MM)
Completed
3
389
Europe
Cyclophosphamide, Lenalidomide, Dexamethasone, Melphalan
Fondazione EMN Italy Onlus
Multiple Myeloma
09/21
07/24
FORTE, NCT02203643: Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.

Active, not recruiting
2
477
Europe
Carfilzomib, Cyclophosphamide, Lenalidomide, Revlimid, Dexamethasone
Mario Boccadoro
MULTIPLE MYELOMA (MM)
10/16
03/26
Larocca, Alessandra
XPORT-MM-031, NCT05028348 / 2021-001691-41: A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

Jul 2024 - Dec 2024: Top-line data from XPORT-MM-031 trial in combination with pomalidomide and dexamethasone for multiple myeloma
Hourglass Jul 2024 - Dec 2024 : H2'24 - Market entry in Malaysia in combination with bortezomib and dexamethasone for r/r MM
Recruiting
3
222
Europe, US
Selinexor, KPT-330, Elotuzumab, Pomalidomide, Dexamethasone Oral
Stichting European Myeloma Network, Karyopharm Therapeutics Inc
Multiple Myeloma
03/26
03/29
NCT04135079: Immune Profiling in Multiple Myeloma

Completed
N/A
50
Europe
Mario Boccadoro
Multiple Myeloma
04/21
12/24
MY MYELOMA, NCT05001087: A "Physician & Patient-powered" Cohort Registry

Recruiting
N/A
1900
Europe
Observation
Fondazione EMN Italy Onlus
Multiple Myeloma
03/24
03/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Palumbo, Antonio
NCT01091831 / 2008-008599-15: Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects

Checkmark ASH 2014
Nov 2014 - Nov 2014: ASH 2014
Checkmark P3 data: ASH (MM)
Nov 2013 - Nov 2013: P3 data: ASH (MM)
Completed
3
389
Europe
Cyclophosphamide, Lenalidomide, Dexamethasone, Melphalan
Fondazione EMN Italy Onlus
Multiple Myeloma
09/21
07/24
FORTE, NCT02203643: Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.

Active, not recruiting
2
477
Europe
Carfilzomib, Cyclophosphamide, Lenalidomide, Revlimid, Dexamethasone
Mario Boccadoro
MULTIPLE MYELOMA (MM)
10/16
03/26
Larocca, Alessandra
XPORT-MM-031, NCT05028348 / 2021-001691-41: A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

Jul 2024 - Dec 2024: Top-line data from XPORT-MM-031 trial in combination with pomalidomide and dexamethasone for multiple myeloma
Hourglass Jul 2024 - Dec 2024 : H2'24 - Market entry in Malaysia in combination with bortezomib and dexamethasone for r/r MM
Recruiting
3
222
Europe, US
Selinexor, KPT-330, Elotuzumab, Pomalidomide, Dexamethasone Oral
Stichting European Myeloma Network, Karyopharm Therapeutics Inc
Multiple Myeloma
03/26
03/29
NCT04135079: Immune Profiling in Multiple Myeloma

Completed
N/A
50
Europe
Mario Boccadoro
Multiple Myeloma
04/21
12/24
MY MYELOMA, NCT05001087: A "Physician & Patient-powered" Cohort Registry

Recruiting
N/A
1900
Europe
Observation
Fondazione EMN Italy Onlus
Multiple Myeloma
03/24
03/24

Download Options